Vantive Sponsored Session: Sepsis: Novel Blood Purification Technologies
Description:
This session was part of Sepsis Alliance Summit 2026
Septic shock remains a leading cause of mortality in critically ill patients, with limited therapeutic options beyond supportive care. This sponsored session will review emerging blood purification strategies designed to target the pathophysiologic drivers of sepsis, with a focus on endotoxin removal and extracorporeal therapies. Using the recently published TIGRIS trial as a guide, Dr. Javier Neyra will examine the rationale for polymyxin B hemoadsorption in patients with endotoxic septic shock, key efficacy and safety findings, and the implications for precision medicine approaches in sepsis care.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Session Supporter:
Sepsis Alliance gratefully acknowledges the support of this session provided by Vantive.
Javier Neyra, MD, MSCS
Professor of Medicine, Division of Nephrology
University of Alabama at Birmingham
Javier Neyra, MD, MSCS, is a Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB), where he serves as Associate Director of the UAB Nephrology Research and Training Center and Co-Director of the Critical Care Nephrology Program. He is an internationally recognized expert in critical care nephrology, acute kidney injury, renal replacement therapies, and extracorporeal blood purification technologies.
Dr. Neyra earned his medical degree from Universidad Peruana Cayetano Heredia in Lima, Peru, completed his Internal Medicine residency at Henry Ford Hospital, and pursued fellowship training in Nephrology and Clinical Research at UT Southwestern Medical Center, where he also earned a Master of Science in Clinical Sciences.
His research focuses on improving outcomes for critically ill patients through innovative approaches to organ support, precision medicine, and blood purification therapies. Dr. Neyra served as a lead investigator of the TIGRIS trial, a landmark study evaluating polymyxin B hemoadsorption for endotoxic septic shock, and has authored numerous peer-reviewed publications in critical care and nephrology.